| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2021 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | EXELIXIS, INC. | $60,000 | |
| 2021 4th Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | ADAPTIVE BIOTECHNOLOGIES | $70,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS | $30,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | RIGEL PHARMACEUTICALS INC. | — | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | AMERICAN GERIATRICS SOCIETY | $20,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | $40,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | EXELIXIS, INC. | $60,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | ADAPTIVE BIOTECHNOLOGIES | $80,000 | |
| 2021 3rd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | CHILDRENS HEALTH SYSTEM OF TEXAS | $90,000 | |
| 2021 2nd Quarter - Report |
ARNOLD & PORTER KAYE SCHOLER LLP | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | $30,000 |